The company’s ARA already bears FDA GRAS affirmation in the United States.
Under its infant formula directive, the European Commission has authorized Cargill’s (Minneapolis) arachidonic acid (ARA) fatty acid as a novel food for use in infant formula and formulas for older children. The company’s ARA already bears FDA GRAS affirmation in the United States.
ARA is an omega-6 long-chain polyunsaturated fatty acid that is a natural component of milk in human mothers. According to Cargill, ARA is included in most infant formulas on the market, promoting infant brain and vision development and often included in conjunction with DHA omega-3 fatty acid, at an approximate ARA:DHA ratio of 2:1.
Cargill greatly increased its ARA capacity in 2010 when it opened an ARA facility in Gedian, China, in partnership with Cargill Alking Bioengineering.
“Cargill is pleased that we now have the opportunity to help our European customers develop premium infant formulas using Cargill’s ARA,” said David Henstrom, Cargill Health & Nutrition’s vice president, in a press release.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
U.S. Hemp Authority announces Adult Use Hemp Product Certification Program
April 15th 2024The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”